Skip to main content
Premium Trial:

Request an Annual Quote

To Review or Not to Review

DrugMonkey wonders about the ethics of reviewing a manuscript that you've already reviewed for another journal. The post says it's OK to accept these articles for review, but wonders if reviewers have an obligation to tell the editor that the article has already been rejected by another journal. "As an author, I think that on the whole I would prefer that the editor be informed when a reviewer has seen the paper before. As a reviewer all I can say is that I do generally indicate this to the editor," writes DrugMonkey.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.